Charlestown, MA, United States of America

Megan E Hnatow

This inventor holds 3 USPTO granted patents. Top assignees: Pfizer Corporation, Other. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Megan E Hnatow. Retrieved from https://idiyas.com/inventor/megan-e-hnatow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Megan E Hnatow

Introduction

Megan E Hnatow is a notable inventor based in Charlestown, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of 5-lipoxygenase inhibitors. With a total of 3 patents to her name, her work has had a meaningful impact on medical research and drug development.

Latest Patents

Megan's latest patents include a process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems. This innovative approach has the potential to enhance the efficacy of treatments related to inflammatory diseases.

Career Highlights

Throughout her career, Megan has worked with prominent organizations, including Pfizer Corporation. Her experience in such a reputable company has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Megan has collaborated with esteemed colleagues, including Timothy Norris and John F Lambert. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Megan E Hnatow's contributions to the field of pharmaceuticals exemplify her dedication to innovation and research. Her work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…